Skye Bioscience (SKYE) Gets a Buy from Scotiabank
Scotiabank analyst George Farmer maintained a Buy rating on Skye Bioscience (SKYE – Research Report) today and set a price target of $20.00.
Adaptimmune price target lowered to $1.40 from $3.15 at Scotiabank
Scotiabank analyst George Farmer lowered the firm’s price target on Adaptimmune (ADAP) to $1.40 from $3.15 and keeps an Outperform rating on ...